You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

nirogacestat

Showing 1 - 12 of 12
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Desmoid Tumor Trial in Palo Alto (Nirogacestat, Cryoablation)

Not yet recruiting
  • Desmoid Tumor
  • Nirogacestat
  • Cryoablation
  • Palo Alto, California
    Stanford University
Jul 7, 2023

Tumor Trial in Houston (Nirogacestat)

Not yet recruiting
  • Tumor
  • Nirogacestat
  • Houston, Texas
    M D Anderson Cancer Center
May 18, 2023

Multiple Myeloma, Tumors, Tumor, Plasma Cell Trial (Belantamab Mafodotin-Blmf, Lenalidomide, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • +7 more
  • Belantamab Mafodotin-Blmf
  • +3 more
  • (no location specified)
Oct 11, 2022

Multiple Myeloma Trial in United States (Belantamab Mafodotin, Nirogacestat)

Recruiting
  • Multiple Myeloma
  • Belantamab Mafodotin
  • Nirogacestat
  • Basking Ridge, New Jersey
  • +6 more
Oct 5, 2022

Multiple Myeloma Trial in United States (Belantamab Mafodotin, Nirogacestat)

Not yet recruiting
  • Multiple Myeloma
  • Belantamab Mafodotin
  • Nirogacestat
  • Basking Ridge, New Jersey
  • +6 more
Mar 2, 2022

Ovarian Granulosa-Stromal Tumor, Ovarian Granulosa Cell Tumor, Ovarian Cancer Trial in Canada, Poland, United States

Recruiting
  • Ovarian Granulosa-Stromal Tumor
  • +2 more
  • Nirogacestat
  • Los Angeles, California
  • +20 more
Jul 13, 2022

Relapsed/Refractory Multiple Myeloma Trial in United States (PBCAR269A, Fludarabine, Cyclophosphamide)

Recruiting
  • Relapsed/Refractory Multiple Myeloma
  • PBCAR269A
  • +3 more
  • Duarte, California
  • +4 more
Jun 24, 2021

Relapsed/Refractory Multiple Myeloma Trial in United States (genetic, biological, drug)

Recruiting
  • Relapsed/Refractory Multiple Myeloma
  • ALLO-715
  • +4 more
  • Gilbert, Arizona
  • +11 more
Feb 18, 2022

Multiple Myeloma Trial in Spain (REGN5458, Daratumumab, Carfilzomib)

Recruiting
  • Multiple Myeloma
  • Athens, Greece
  • +8 more
Nov 30, 2022

Desmoid Fibromatosis, Recurrent Desmoid Fibromatosis, Unresectable Desmoid Fibromatosis Trial in Worldwide (Nirogacestat,

Active, not recruiting
  • Desmoid Fibromatosis
  • +2 more
  • Nirogacestat
  • +2 more
  • Birmingham, Alabama
  • +95 more
Dec 13, 2022

Multiple Myeloma Trial in Worldwide (Teclistamab, Daratumumab, Pomalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +26 more
Jan 17, 2023

Relapsed/Refractory Multiple Myeloma Trial in Worldwide (ABBV-383, Dexamethasone, Lenalidomide)

Not yet recruiting
  • Relapsed/Refractory Multiple Myeloma
  • Little Rock, Arkansas
  • +45 more
Jul 8, 2022